{"id":"NCT02545049","sponsor":"Bayer","briefTitle":"Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-17","primaryCompletion":"2021-02-02","completion":"2021-02-02","firstPosted":"2015-09-09","resultsPosted":"2022-04-15","lastUpdate":"2022-04-15"},"enrollment":7352,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Kidney Disease"],"interventions":[{"type":"DRUG","name":"Finerenone (BAY94-8862)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BAY94-8862","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.","primaryOutcome":{"measure":"The First Occurrence of the Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non Fatal Stroke, or Hospitalization for Heart Failure.","timeFrame":"From randomization up until the first occurrence of the CV composite endpoint, or censoring at the end of the study, with an average study duration of 41 months.","effectByArm":[{"arm":"Finerenone","deltaMin":458,"sd":null},{"arm":"Placebo","deltaMin":519,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0264"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":975,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","China","Colombia","Czechia","Denmark","Finland","France","Germany","Greece","Hong Kong","Hungary","Ireland","Israel","Italy","Japan","Lithuania","Malaysia","Mexico","Netherlands","New Zealand","Norway","Philippines","Poland","Portugal","Puerto Rico","Romania","Russia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom","Vietnam"]},"refs":{"pmids":["31665733","34449181","40315020","40021271","39380152","38508632","38048573","38046911","37745646","36927680","36864892","36639130","36328655","36287567","36251465","34775784","33358451","33280027"],"seeAlso":["http://www.clinicaltrialsregister.eu/","http://clinicaltrials.bayer.com/"]},"adverseEventsSummary":{"seriousAny":{"events":1158,"n":3683},"commonTop":["Nasopharyngitis","Arthralgia","Back pain","Hypertension","Hyperkalaemia"]}}